Hematopoietic and Lymphatic System Neoplasm

Hematopoietic and Lymphatic System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

18,827 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1,351–1,400 of 1,414 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04624958	Zanubrutinib and Rituximab Followed by R-DHAOx Then Maintenance with Zanubrutinib for Newly-Diagnosed MCL	active not recruiting	Phase 2	42	Sun Yat-sen UniversityOTHER	1	Oct 18, 2024	clinicaltrials
NCT05202782	Zanubrutinib and CAR T-cell Therapy for the Treatment of Recurrent or Refractory Aggressive B-cell Non-Hodgkin's Lymphoma or Transformed Indolent B-cell Lymphoma	active not recruiting	Phase 2	24	Northwestern UniversityOTHER	1	Oct 16, 2024